0.2230
+0.0010
+(0.45%)
At close: April 17 at 4:00:00 PM EDT
0.2109
-0.01
(-5.43%)
After hours: April 17 at 6:58:25 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-31,098.0780
-31,098.0780
-34,879.9030
-46,457.4880
-57,489.5300
Investing Cash Flow
20.0280
20.0280
-21.3940
-84.1910
-14.9430
Financing Cash Flow
5.3980
5.3980
28,823.5080
4,157.4080
10,724.3460
End Cash Position
10,720.1780
10,720.1780
41,792.8300
47,870.6190
90,254.8900
Capital Expenditure
-9.9720
-9.9720
-21.3940
-84.1910
-14.9430
Issuance of Capital Stock
--
--
28,707.0110
4,157.4080
10,699.3170
Free Cash Flow
-31,108.0500
-31,108.0500
-34,901.2970
-46,541.6790
-57,504.4730
12/31/2021 - 1/10/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
STRO Sutro Biopharma, Inc.
0.5246
-2.85%
KALA KALA BIO, Inc.
3.4550
+2.52%
URGN UroGen Pharma Ltd.
9.67
-6.93%
CLRB Cellectar Biosciences, Inc.
0.2990
+5.58%
AEON AEON Biopharma, Inc.
0.4050
+1.28%
ASMB Assembly Biosciences, Inc.
10.03
+0.25%
SYRE Spyre Therapeutics, Inc.
12.67
+2.01%
ADVM Adverum Biotechnologies, Inc.
2.9300
-1.68%
MGNX MacroGenics, Inc.
1.2600
+6.78%
COGT Cogent Biosciences, Inc.
4.3700
+2.34%